Cite

HARVARD Citation

    Monteagudo, M. et al. (2015). Efficacy, safety and tolerability of rivaroxaban for the secondary prevention of stroke in patients with atrial fibrillation in clinical practice. Future neurology. pp. 529-536. [Online]. 
  
Back to record